Concepedia

Publication | Open Access

Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer

DOIFull Paper Access

79

Citations

37

References

2015

Year

Zhang Liang, Xiaoen Wang, Andrea J. Bullock, Marcella Callea, Harleen Shah, Jiaxi Song, Kelli Moreno, Barbara Visentin, Douglas H. Deutschman, David C. Alsop,
Clinical Cancer Research

Abstract

Our findings suggest that S1P inhibition may be a novel therapeutic strategy in patients with treatment-naïve RCC and also in the setting of resistance to VEGFR TKI therapy.

References

YearCitations

Page 1